interleukin-2 gene therapy (TKT)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinterleukin-2 gene therapy (TKT)
Drug Alias NameIL-2 gene therapy (Transkaryotic Therapies)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShire Human Genetic Therapies, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Human Genetic Therapies, Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A